Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 6, 2006, Pages 1656-1659

  Oh, Sangtae ^a   Jeong, In Howa ^a   Shin, Woon Seob ^b   Wang, Qian ^c   Lee, Seokjoon ^b,c  

^a Yonsei University Wonju   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiogenesis; Anticancer; Hedychilactone A; Natural product; NO production; Organic synthesis

Indexed keywords

HEDYCHILACTONE; LACTONE DERIVATIVE; NITRIC OXIDE; PLANT EXTRACT; SCLAREOLIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; NONHUMAN; STRUCTURE ACTIVITY RELATION; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; CELLS, CULTURED; DITERPENES; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; UMBILICAL VEINS;

EID: 32044439656     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.12.009     Document Type: Article

References (17)

1. H. Itogawa, H. Morita, I. Katou, K. Takeya, A.J. Cavalheiro, R.C.B. de Olivera, M. Ishige, and M. Motidome Planta Med. 1987 311
2. H. Itogawa, H. Morita, K. Takeya, and M. Motidome Chem. Pharm. Bull. 36 1988 2682
3. M. Jung, I. Ko, and S. Lee J. Nat. Prod. 61 1998 1394
4. M. Jung, I. Ko, S. Lee, S.J. Choi, B.H. Youn, and S.K. Kim Bioorg. Med. Chem. Lett. 8 1998 3295
5. S. Oh, I.H. Jeong, W.-S. Shin, and S. Lee Bioorg. Med. Chem. Lett. 13 2003 2009
6. H. Matsuda, T. Morikawa, Y. Sakamoto, I. Toguchida, and M. Yoshikawa Bioorg. Med. Chem. 10 2002 2527
7. H. Matsuda, T. Morikawa, Y. Sakamoto, I. Toguchida, and M. Yoshikawa Chem. Pharm. Bull. 50 2002 1045
8. H. Matsuda, T. Morikawa, Y. Sakamoto, I. Toguchida, and M. Yoshikawa Heterocycles 56 2002 45
9. M. Sekiguchi, H. Shigemori, A. Ohsaki, and J. Kobayashi J. Nat. Prod. 64 2001 1102
10. M.C. de la Torre, I. Garcia, and M.A. Sierra Tetrahedron Lett. 43 2002 6351
11. 3) δ 170.2, 150.1, 144.4, 123.2, 104.3, 73.7, 65.2, 55.3, 52.9, 41.8, 39.2, 38.7, 33.9, 33.4, 33.3, 28.9, 22.6, 21.5, 19.1, 14.3.
12. 3) δ 170.1, 146.6, 134.0, 123.4, 121.7, 65.2, 55.0, 50.1, 42.1, 39.7, 36.7, 33.2, 32.8, 29.0, 25.7, 23.6, 22.2, 21.9, 18.7, 14.2.
13. T. Mosmann J. Immunol. Methods 65 1983 55
14. D.A. Spikins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C.P. Li Nat. Med. 4 1998 623
15. P. Alessi, C. Ebbinghaus, and D. Neri Biochim. Biophys. Acta 1654 2004 39
16. A. Dirksen, S. Langereis, B.F.M. de Waal, M.H.P. van Genderen, T.M. Hackeng, and E.W. Meijer Chem. Commun. 1 2005 2811
17. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Biochemistry 126 1982 131